Kenneth E. Thummel
University of Washington · 331 works · 27,679 citations · h-index 85
Top works
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
- Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
- Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism
- Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*
- Genetic contribution to variable human CYP3A-mediated metabolism
- Human liver carbamazepine metabolism
- Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test
- Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
- Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
- Vinylalkohol, ein ständiger Begleiter des Aethyläthers
- Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
- Expression of Enzymatically Active CYP3A4 by Caco-2 Cells Grown on Extracellular Matrix-Coated Permeable Supports in the Presence of 1α,25-Dihydroxyvitamin D3
- First-pass metabolism of midazolam by the human intestine*
- Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4
- New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process
- Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
- Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
- Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
- Metabolic Drug Interactions